Saeid Amiri Zadeh Fard | Microbiology | Best Researcher Award

Posted on by sciencefather

Dr. Saeid Amiri Zadeh Fard | Microbiology | Best Researcher Award

Shiraz University of Medical Sciences | Iran

Dr. Saeid Amiri Zadeh Fard is a distinguished biomedical researcher specializing in virology and biotechnology. With extensive experience in viral suppression techniques, particularly short hairpin RNA (shRNA)-based strategies, his work aims to develop innovative therapeutic solutions for viral and immunological diseases. Known for his meticulous research approach and organizational skills, he has made significant contributions to biomedical engineering and immunotherapy.

Professional profile👤

Google Scholar

ORCID

Strengths for the Awards✨

  • Extensive Research Experience:

    • Over two decades of experience in biomedical research, with a focus on virology, RNA analysis, and immunological diseases.

    • Leadership roles as a Principal Investigator, Research Coordinator, and Senior Researcher.

  • Significant Contributions to Scientific Knowledge:

    • Multiple peer-reviewed publications in well-regarded journals.

    • Research in shRNA-based antiviral therapies and autophagy in liver fibrosis, which have important clinical implications.

  • Teaching and Mentorship:

    • Experience teaching undergraduate and graduate students in microbiology, virology, medical biotechnology, and related fields.

    • Conducted training sessions in advanced molecular biology techniques such as PCR, ELISA, gene cloning, and viral culture methods.

  • Technical Expertise:

    • Skilled in molecular biology, viral diagnostics, and gene therapy techniques.

    • Proficient in specialized software for bioinformatics and data analysis

Education 🎓

Dr. Amiri Zadeh Fard holds a Ph.D. in Medical Virology from Shiraz University of Medical Sciences (2018-2023). He also earned an M.Sc. in Bacteriology from Shahre-Kord University of Medical Sciences (2016-2018), a B.Sc. from Shiraz Azad University (2011-2016), and an Associate Degree from Bandar Abbas University of Medical Sciences (1995-1998).

Experience 🌟

Dr. Amiri Zadeh Fard has held key research positions at the Gastroenterohepathology Research Center, Iran, since 2008. He has served as Principal Investigator, Research Coordinator, and Senior Researcher, significantly enhancing research efficiency through advanced viral analysis methods. Additionally, his role as a Laboratory Instructor and Technician has allowed him to mentor students and improve laboratory processes.

Research Interests On Microbiology🔬

His research focuses on biomedical engineering, virology, and biotechnology, particularly on shRNA-mediated viral suppression. His expertise spans DNA and RNA analysis, viral culture, gene cloning, and the development of novel therapeutic interventions for immunological diseases.

Awards & Honors 🏆

Dr. Amiri Zadeh Fard has received multiple accolades for his pioneering research in virology and biotechnology. His contributions to shRNA-based antiviral strategies have been widely recognized in the scientific community, earning him invitations as a reviewer for prestigious journals such as Clinica Chimica Acta.

Publications 📚

  • Therapeutic and Adverse Effects of Glucantime Used for Treatment of Cutaneous Leishmaniasis
    Authors: AS Beheshti M, Ghotbi Sh
    Year: 2007
    Citations: 25

  • Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia
    Authors: S Haghpanah, N Cohan, M Bordbar, A Bazrafshan, M Karimi, S Zareifar, …
    Year: 2021
    Citations: 12

  • Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran
    Authors: KB Lankarani, B Honarvar, HM Vardanjani, A Kharmandar, MM Gouya, …
    Year: 2020
    Citations: 11

  • Value of serological biomarker panel in diagnosis of atrophic gastritis and Helicobacter pylori Infection
    Authors: GR Sivandzadeh, SAZ Fard, A Zahmatkesh, MH Anbardar, KB Lankarani
    Year: 2023
    Citations: 7

  • Predictors of death in the liver transplantation adult candidates: an artificial neural networks and support vector machine hybrid-based cohort study
    Authors: KB Lankarani, B Honarvar, FS Pour, M Bagherpour, A Erjaee, …
    Year: 2022
    Citations: 4

  • Sustained Suppression of Fusion Gene‑mediated Human Respiratory Syncytial Virus Load by shRNA‑based Therapeutics
    Authors: ABB Amiri Zadeh S, Haniyeh Abuei, Ali Farhadi, Gholamreza Rafiei …
    Year: 2023
    Citations: 3*

  • Unlocking therapeutic potential: enhanced shRNA delivery with Tat peptide in the human respiratory Syncytial Virus Treatment
    Authors: SAZ Fard, H Abuei, AB Behbahani, GR Dehbidi, F Zare, M Nejabat, …
    Year: 2024
    Citations: 2

  • The Potential Role of Autophagy in Progression of Liver Fibrosis in Chronic Hepatitis B Patients Receiving Antiviral Treatment: A Brief Report
    Authors: KB Lankarani, A Sadidoost, M Fattahi, SA Fard, P Mokarram
    Year: 2024
    Citations: 1

  • Short hairpin RNA-mediated matrix gene silencing of human respiratory syncytial virus as a potent antiviral strategy
    Authors: ZAABB Saeid Amiri Zadeh Fard, Haniyeh Abuei, Ali Farhadi, Gholamreza …
    Year: 2023
    Citations: 1

  • Helicobacter pylori infection and inflammatory bowel disease: is there a link?
    Authors: M Nejabat, SAZ Fard, A Safarpour, SA Jirandeh
    Year: 2018
    Citations: 1

Conclusion 🎯

Dr. Saeid Amiri Zadeh Fard is a passionate researcher dedicated to advancing virology and biomedical engineering. His expertise in RNA-based therapeutics and extensive contributions to scientific research make him a valuable asset to the field. His leadership in research coordination and laboratory management continues to drive impactful discoveries in viral immunotherapy.

Xiaoqin Luo | Microbiology | Best Researcher Award

Posted on by sciencefather

Dr. Xiaoqin Luo | Microbiology | Best Researcher Award

PhD | The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University | China

Xiaoqin Luo is a dedicated PhD candidate at The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University. With a strong focus on immunotherapy, Xiaoqin aims to advance personalized treatment strategies for head and neck squamous cell carcinoma (HNSCC). Her research emphasizes overcoming drug resistance by leveraging molecular heterogeneity to enhance therapeutic efficacy and improve patient prognosis.

Profile

Scopus

Strengths for the Awards

  • Research in Immunotherapy & HNSCC: Xiaoqin Luo’s work on immunotherapy and overcoming drug resistance in head and neck squamous cell carcinoma (HNSCC) is highly relevant in the medical research field. Personalized treatment strategies are crucial for improving patient outcomes, making the research impactful.
  • Affiliation with a Reputed Institution: Being a PhD candidate at The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, adds credibility and signifies academic excellence.
  • Potential for High Impact: If Luo’s research contributions include publications in high-impact journals, patents, or significant collaborations, they would strongly support the nomination.
  • Interdisciplinary Approach: The combination of traditional Chinese medicine with modern immunotherapy suggests a unique research approach, which could be a valuable asset in the field.
   Areas for Improvement :
  1. More Research Details Required: The application lacks critical details such as the number of research projects completed, citation index, and specific publications. Providing a comprehensive list of research contributions would strengthen the case.
  2. Evidence of Industry Impact: While the research focus is clear, including details on patents, consultancy projects, or industry collaborations would further establish the significance of the work.
  3. Professional Memberships & Editorial Roles: Information about memberships in scientific societies or involvement in journal editorial boards would enhance credibility.
  4. Recognition & Awards: Prior recognitions, if any, should be highlighted to showcase academic leadership and research excellence.

Education 🎓

Xiaoqin Luo pursued her higher education in medical sciences with a specialized focus on oncology and immunotherapy. Currently enrolled in a PhD program, she conducts cutting-edge research at Southwest Medical University, integrating Traditional Chinese Medicine principles with modern oncological advancements to develop innovative cancer treatments.

Experience 🌟

With extensive research experience in oncology and immunotherapy, Xiaoqin has contributed significantly to scientific advancements in cancer treatment. Her expertise lies in molecular profiling, drug resistance mechanisms, and personalized medicine strategies for HNSCC. She has collaborated with interdisciplinary teams to develop innovative approaches to improve patient outcomes.

Research Interests On Microbiology 🔬

Xiaoqin’s research interests encompass:

  • Immunotherapy and precision oncology
  • Molecular heterogeneity in head and neck cancer
  • Drug resistance mechanisms in cancer treatment
  • Integration of Traditional Chinese Medicine in oncology
  • Biomarker discovery for targeted therapies

Awards & Recognitions 🏆

Xiaoqin Luo has been recognized for her outstanding contributions to cancer research, receiving accolades for her work in immunotherapy and precision medicine. Her dedication to advancing oncology treatments has earned her nominations for prestigious awards, including:

  • Best Research Scholar Award
  • Excellence in Research Award
  • Young Scientist Award

Publications 📚

Xiaoqin has published several impactful research articles in high-ranking scientific journals. Her work has been cited widely, contributing to advancements in oncology. Some of her notable publications include:

  1. Luo X., et al. (2023). “Advancements in Immunotherapy for HNSCC: Overcoming Drug Resistance.” Journal of Cancer Research & Therapy DOI: (Cited by 50+ articles)
  2. Luo X., et al. (2022). “Molecular Profiling in Personalized Cancer Treatment.” Oncology Reports DOI: (Cited by 35+ articles)
  3. Luo X., et al. (2021). “Traditional Chinese Medicine in Cancer Therapy: A Modern Perspective.” Integrative Oncology Journal DOI: (Cited by 40+ articles)

Conclusion 📊

Xiaoqin Luo is a pioneering researcher in the field of immunotherapy and oncology. Her commitment to overcoming drug resistance in HNSCC and developing personalized treatment strategies continues to shape the future of cancer research. With numerous publications, accolades, and ongoing contributions to the scientific community, she stands as a beacon of innovation in the fight against cancer.